Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
06 sept. 2023 08h30 HE
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
03 août 2022 07h05 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...